Keywords: genzyme, debut, gleevec, resistance, biotechnology, firm, announced

Genzyme debut Gleevec resistance test

Article | 13 February 2006

Print This

US biotechnology firm Genzyme has announced the availability of a new test to monitor drug resistance in chronic myeloid leukemia ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in